National Institutes of Health logo
NIH STTR

NIH STTR Phase I (Omnibus)

Funds United States small businesses partnering with nonprofit research institutions to validate biomedical ideas.

OpenNational Institutes of HealthUnited States

The NIH STTR Phase I Omnibus is the Small Business Technology Transfer program's feasibility-stage grant, issued under activity code R41, and is designed specifically to bridge university and research-institution discoveries into commercial development through a formal small business partnership. STTR Phase I awards carry the same $306,872 total-cost cap and same six-to-twelve-month performance pe…

Same biomedical and behavioral-health scope as SBIR Phase I, with explicit collaboration between a small business and a non-profit research institution.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.5 Jan 2027
Decision timeiTypical time from the deadline to the funder's decision.32 weeks
Project durationiHow long the funded work is expected to run.1–12 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.$50M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
National Institutes of Health logo
Open

Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)

🇺🇸NIH · United States

Funds the design and early validation of frameworks — guidelines, protocols and standard procedures — for building and deploying multimodal medical AI reliably.

AIMedtech
$300KOct'26
National Institutes of Health logo
Open

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers

🇺🇸NIH · United States

Funds a clinical centre inside a consortium testing how to use anti-obesity medication in children without harming their growth or mental health.

Biotech
$1MOct'26
National Institutes of Health logo
Open

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center

🇺🇸NIH · United States

Funds the single centre that runs statistics, data and coordination for the consortium testing anti-obesity medication in children.

Oct'26
National Institutes of Health logo
Open

Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)

🇺🇸NIH · United States

Funds work on the methodological problems that make trials of rapid-acting psychotropic drugs hard to interpret, and on sustaining the treatment afterwards.

Biotech
Oct'26
National Institutes of Health logo
Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer

🇺🇸NIH · United States

Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.

BiotechMedtech+1
Oct'26
National Institutes of Health logo
Open

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3)

🇺🇸NIH · United States

Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.

BiotechMedtech
$250KOct'26